): The objective of this postdoctoral program in Cancer Biology is to provide an integrated educational experience to prepare its fellows for successful independent research careers in the area of cancer biology. A major distinguishing feature of this proposal is its e m phasis on basic research conducted within the context of existing interdisciplinary programs, all of which are integrated under the aegis of the Massey Cancer Center. Specifically, these programs include: Developmental Therapeutics, Cancer Cell Biology, Immune Mechanisms, and Radiation Biology and Oncology. This postdoctoral training grant in Cancer Biology is designed to bring together the strengths of selected, extramurally funded faculty within different departments at Virginia Commonwealth University whose research relates to specific areas of cancer biology. This program takes advantage of the leadership of Dr. Gordon D. Ginder, the recently recruited Director of the Massey Cancer Center, as well as the contributions of a number of both junior and senior faculty members who bring a unique spectrum of strengths and experience in diverse areas of cancer biology. The involvement of these individuals within the Cancer Biology training grant should foster productive collaborations leading to new research initiatives, and should p r o v ide a fertile environment for training of young investigators. Furthermore, the Massey Cancer Center, in coordination with various basic science departments, is in the process of recruiting at least ten additional faculty members who will eventually be incorporated into the training program. The focus on a training program based within the Cancer Center rather than through a single department, provides for a greater breadth of training experience for its trainees.
| Terracina, Krista P; Graham, Laura J; Payne, Kyle K et al. (2016) DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer. Cancer Immunol Immunother 65:1061-73 |
| Nagahashi, Masayuki; Yamada, Akimitsu; Miyazaki, Hiroshi et al. (2016) Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods. J Mammary Gland Biol Neoplasia 21:9-17 |
| Shapiro, Brian A; Vu, Ngoc T; Shultz, Michael D et al. (2016) Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKC? Signaling Axis. J Biol Chem 291:21669-21681 |
| Terracina, Krista P; Aoyagi, Tomoyoshi; Huang, Wei-Ching et al. (2015) Development of a metastatic murine colon cancer model. J Surg Res 199:106-14 |
| Nagahashi, Masayuki; Takabe, Kazuaki; Terracina, Krista P et al. (2014) Sphingosine-1-phosphate transporters as targets for cancer therapy. Biomed Res Int 2014:651727 |
| Aoyagi, Tomoyoshi; Terracina, Krista P; Raza, Ali et al. (2014) Current treatment options for colon cancer peritoneal carcinomatosis. World J Gastroenterol 20:12493-500 |
| Biddlestone-Thorpe, Laura; Sajjad, Muhammad; Rosenberg, Elizabeth et al. (2013) ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation. Clin Cancer Res 19:3189-200 |
| Tang, Yong; Hamed, Hossein A; Poklepovic, Andrew et al. (2012) Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors. Mol Pharmacol 82:322-32 |
| Shultz, Jacqueline C; Vu, Ngoc; Shultz, Michael D et al. (2012) The Proto-oncogene PKC? regulates the alternative splicing of Bcl-x pre-mRNA. Mol Cancer Res 10:660-9 |
| Tang, Yong; Hamed, Hossein A; Cruickshanks, Nichola et al. (2012) Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. Mol Pharmacol 81:527-40 |
Showing the most recent 10 out of 28 publications
